Trial intelligence / Profile preview

Tdap Vaccine in HIV-Infected and Uninfected Pregnant Women

NCT04589312Phase 2Completed

Sponsor
St George's, University of London
Start
Oct 2020
Primary completion
Jun 2023
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of Boostagen in pertussis, sponsored by St George's, University of London. Started Oct 2020; status: completed.

02

Drugs

Boostagen
03

Conditions

pertussis

Beyond the preview

Go deeper on NCT04589312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04589312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call